@calder_eli
Account based inSpain
About this account
- Account based in
- Spain
- Connected via
- Spain Android App
Account-level information from X, not a live location or the device used for a specific post.
PhD in Immunology
Barcelona, Spain
Joined March 2016
- Tweets421
- Following307
- Followers136
- Likes2.1K
Elisabeth Calderón retweeted
The long-awaited 2024 update and phenotypic classification are here:
The first JHI articles are online! Poli et al present the 2024 update of the @iuis_online classification of #InbornErrorsOfImmunity (hubs.la/Q03hwdHg0) & Bousfiha et al provide an accompanying phenotypic classification to assist clinical diagnoses (hubs.la/Q03hvT0f0)
Elisabeth Calderón retweeted
The IUIS Inborn Errors Update is online!
The 2024 IUIS Inborn Errors of Immunity (IEI) Classification has arrived! Explore our latest insights now at iuis.org/committees/iei. Find the report under “Annual 2024 Report”!
Elisabeth Calderón retweeted
Do not miss this #postdoctoral opportunity in our team!
🚨 #JobAlert🚨
Join our lab at @CarrerasIJC in #Barcelona to lead innovative #Epigenetics & #SingleCell #Omics research on #SecondaryImmunodeficiency in #Leukemia patients, funded by #Grifols. Apply! 🌟 DM me for details! institut-josep-carreras-ijc.…
Elisabeth Calderón retweeted
Excited to share our latest findings on the complex challenges of diagnosing PID in the context of SID linked to B-cell malignancies. Stay tuned for insights!
link.springer.com/article/10…
Elisabeth Calderón retweeted
Dissecting the crossovers between SID to B hematological malignancy & IEI at @ESIDsociety
San Carlos Immunology team
#somosclinico
Elisabeth Calderón retweeted
Engineered T cells (CAR T) is a transformative Rx for cancer and emerging for autoimmune diseases.
A meta-analysis of >7,600 patients in 18 clinical trials and 28 real-world studies highlights the risk of infection during follow-up as the principal cause of non-relapse mortality
nature.com/articles/s41591-0…
@NatureMedicine @KRejeski @DavidCdSMD @MSKCancerCenter
Elisabeth Calderón retweeted
🌍 Our first day at the Global Stakeholders Summit is actively unfolding with vibrant discussions, exploring new horizons and innovations for global progress in PIDs!
#GlobalStakeholdersSummit #PIDs #Innovation
Elisabeth Calderón retweeted
Economic Impact of Immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer. A single center observational study
frontiersin.org/journals/imm…
Elisabeth Calderón retweeted
Do not miss it!!! #PrimaryImmunodeficiencies @hospitaldelmar
📢 Conferència "Antibody deficiency: what have we learned?"
👩🎓 Ponent: Charlotte Cunningham-Rundles (Icahn School of Medicine at Mount Sinai, USA).
📅🕒 10 de Juny de 2024, a les 15:00h.
📍 Sala Ramon y Cajal (Institut de Recerca de @hospitaldelmar).
⭐️ Molt recomanable!!!
Elisabeth Calderón retweeted
The legendary Dr. Cunningham-Rundles sharing her pearls of wisdom about IG replacement therapy @ClinImmSoc
Opening the CIS meeting 2024 with a Tribute to Vicki Modell by Dr. Orange @ClinImmSoc @jordanorange #CIS2024 #PIDD
Elisabeth Calderón retweeted
Patients with immunodeficiency are often undiagnosed or experience marked delay in detection.
#AI to the rescue.
science.org/doi/10.1126/scit… @ScienceTM @ManishButte @UCLA
Congratulations Dr. Cunningham-Rundles on this Award!
Congratulations to Dr. Charlotte Cunningham-Rundles, recipient of the 2024 Joachim Hilfenhaus Award. She receives this honor for her exceptional contributions to the field of immunology. Learn more about her impressive work at @IcahnMountSinai: profiles.mountsinai.org/char… #IPPC2024
Elisabeth Calderón retweeted
Exploring Gastric Cancer Genetics: A Turning Point in Common Variable Immunodeficiency - ScienceDirect sciencedirect.com/science/ar…
It was a pleasure to meet the three ASPIRE award winners Dr. Laia Alsina (2021), Dr. Emily Edwards (2022) and Dr. Adrian Shields (2023) at #IPIC2023 #IPICmoment @laiaalsina_ @emmye1984 @immunologydoc
How can artificial intellingence help detect patients at risk of primary immunodeficiency? Dr. Nick Rider @NRider70 explained it to us at #IPIC2023 #IPICmoment . Excellent talk!
Fantastic talk by Dr. Pere Soler-Palacín about new tools for PID diagnosis #PID #IPIC2023 #IPICmoment @bcnpidfound @Immuno_HUVH
Congratulations to the ASPIRE award winner 2023 @immunologydoc #IPIC2023#IPICmoment
